Vitamin D levels and bone mass in rheumatoid arthritis

Rheumatology International

Volumn 35, Issue 3, 2015, Pages 499-505

  Brance, María L ^a,b,c   Brun, Lucas R ^b   Lioi, Susana ^a   Sánchez, Ariel ^d   Abdala, Marcelo ^a   Oliveri, Beatriz ^c,e,f  

^a Hospital Centenario de Rosario   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d Centro de Endocrinología ^*  (Argentina)

^e HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Bone mass; Disease activity; Rheumatoid arthritis; Vitamin D

Indexed keywords

25-HYDROXYVITAMIN D; ANTIRHEUMATIC AGENT; VITAMIN D;

ADULT; AGED; ANALOGS AND DERIVATIVES; ARGENTINA; ARTHRITIS, RHEUMATOID; BLOOD; BONE DENSITY; COMPLICATION; FEMALE; FEMUR NECK; HUMAN; LUMBAR VERTEBRA; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; POSTMENOPAUSE; PREMENOPAUSE; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARGENTINA; ARTHRITIS, RHEUMATOID; BONE DENSITY; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84939876015     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3071-6     Document Type: Article

References (38)

1. Lodder MC, de Jong Z, Kostense PJ et al (2004) Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63:1576–1580
2. Cutolo M (2009) Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford) 48:210–212
3. Baykal T, Senel K, Alp F, Erdal A, Ugur M (2012) Is there an association between serum 25-hydroxyvitamin D concentrations and disease activity in rheumatoid arthritis? Bratisl Lek Listy 113:610–611
4. Attar SM (2012) Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med J 33:520–525
5. Turhanoğlu AD, Güler H, Yönden Z, Aslan F, Mansuroğlu A, Ozer C (2011) The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int 31:911–914
6. Cutolo M, Otsa K, Laas K et al (2006) Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 24:702–704
7. Rossini M, Maddali Bongi S, La Montagna G et al (2010) Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 12:R216
8. Andjelkovic Z, Vojinovic J, Pejnovic N et al (1999) Disease modifying and immunomodulatory effects of high dose 1α(OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453–456
9. Chen J, Liu W, Lin Q, Chen L, Yin J, Huang H (2014) Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients. Int J Rheum Dis 17(1):66–70
10. Vis M, Haavardsholm EA, Bøyesen P et al (2011) High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int 22:2413–2419
11. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383–1389
12. Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23:581–587
13. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951
14. Colin EM, Asmawidjaja PS, van Hamburg JP et al (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62:132–142
15. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581
16. Fransen J, van Riel PL (2005) The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 23:S93–S99
17. van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850
18. Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58
19. Sánchez A, Oliveri B, Mansur JL, Fradinger E, Mastaglia S (2013) Diagnosis, prevention, and treatment of hipovitaminosis D. A practical guide. Argentine Federation of Endocrine Societies. Rev Arg Endocrinol Metab 50:140–156
20. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285:785–795
21. Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM (2006) International society for clinical densitometry. Official positions of the international society for clinical densitometry and executive summary of the 2005 position development conference. J Clin Densitom 9:4–14
22. Gopinath K, Danda D (2011) Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis 14:332–339
23. Baker JF, Baker DG, Toedter G, Shults J, Von Feldt JM, Leonard MB (2012) Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 30:658–664
24. Haga HJ, Schmedes A, Naderi Y, Moreno AM, Peen E (2013) Severe deficiency of 25-hydroxyvitamin D(3) (25-OH-D (3)) is associated with high disease activity of rheumatoid arthritis. Clin Rheumatol 32:629–633
25. Higgins MJ, Mackie SL, Thalayasingam N, Bingham SJ, Hamilton J, Kelly CA (2013) The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis. Clin Rheumatol 32:863–867
26. Song GG, Bae SC, Lee YH (2012) Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 31:1733–1739
27. Craig SM, Yu F, Curtis JR, Alarcón GS et al (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol 37:275–281
28. Mastaglia SR, Seijo M, Muzio D, Somoza J, Nuñez M, Oliveri B (2011) Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging 15:349–354
29. Haque UJ, Bartlett SJ (2010) Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 28:745–747
30. Hitchon CA, Sun Y, Robinson DB et al (2012) Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 39:1792–1797
31. Huybers S, Naber TH, Bindels RJ, Hoenderop JG (2007) Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6. Am J Physiol Gastrointest Liver Physiol 292:G92–G97
32. Zallone A (2006) Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci 1068:173–179
33. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319–1328
34. Sugiguchi S, Goto H, Inaba M, Nishizawa Y (2010) Preferential reduction of bone mineral density at the femur reflects impairment of physical activity in patients with low-activity rheumatoid arthritis. Mod Rheumatol 20:69–73
35. Gilboe IM, Kvien TK, Haugeberg G, Husby G (2000) Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis 59:110–115
36. Oliveri B, Di Gregorio S, Parisi MS, Solís F, Mautalen C (2003) Is ultrasound of bone relevant for corticosteroid-treated patients? A comparative study with bone densitometry measured by DEXA. Joint Bone Spine 70:46–51
37. Dirven L, van den Broek M, van Groenendael JH et al (2012) Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord 13:125
38. Mohammad A, Lohan D, Bergin D et al (2013) The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis. Rheumatology (Oxford)